The top pre-market NASDAQ Stock Market gainers are: Ness Technologies, A123 Systems, Vodafone Group, Deckers Outdoor, Melco Crown Entertainment, ARM Holdings and Melco Crown Entertainment. The top pre-market NASDAQ Stock Market losers are: Zion Oil & Gas, Silgan Holdings and Gilead Sciences.

Gainers:

Ness Technologies Inc. (NASDAQ:NSTC) shares climbed 13.17 percent to $7.56 in pre-market trading session. The company announced that it agreed to be acquired by an affiliate of Citi Venture Capital International in a cash transaction valued at about $307 million.

A123 Systems Inc. (NASDAQ:AONE) shares surged 8.19 percent to $4.89 in per-market trading session. The stock has a 52 week low of $4.49 and 52 week high of $11.53 and has $569.34 million market capitalization.

Vodafone Group Plc (NASDAQ:VOD) shares advanced 2.09 percent to $26.32 in pre-market trading session. RBS raised price target on shares of VOD.

Deckers Outdoor Corp. (NASDAQ:DECK) shares advanced 2.76 percent to $79.80 in pre-market trading session.

Melco Crown Entertainment Ltd. (NASDAQ:MPEL) shares advanced 1.73 percent to $10.59 in pre-market trading session.

ARM Holdings, plc (NASDAQ:ARMH) shares gained 1.8 percent to $28.29 in pre-market trading session. The stock has a 52 week low of $12.17 and 52 week high of $32.18 and has $12.64 billion market capitalization.

Melco Crown Entertainment Ltd. (NASDAQ:MPEL) shares gained 1.73 percent to $10.59 in pre-market trading session.

Losers:

Zion Oil & Gas Inc. (NASDAQ:ZN) shares slumped 9.03 percent to $6.98 in pre-market trading session. The stock has a 52 week low of $4.20 and 52 week high of $7.87 and has $175.03 million market capitalization.

Silgan Holdings, Inc. (NASDAQ:SLGN) shares declined 3.82 percent to $41.50 in pre-market trading session.

Gilead Sciences Inc. (NASDAQ:GILD) shares declined 3.06 percent to $39.00 in pre-market trading session. The company received a subpoena from the U.S. Attorney's Office for the Northern District of California requesting documents related to the manufacture, and related quality and distribution practices, of Atripla, Emtriva, Hepsera, Letairis, Truvada, Viread and the company's investigational fixed-dose combination of Truvada and Edurant.

NASDAQ Stock Market California Investment California